The distribution of Atherosclerosis Market Share is characterized by intense competition among global pharmaceutical giants who vie for dominance across the diverse therapeutic segments, from high-volume generics to premium-priced biologics. The largest collective share of the market is held by manufacturers of lipid-lowering therapies, particularly those who maintain patent exclusivity...